Free Trial
NYSE:DLB

Dolby Laboratories (DLB) Stock Price, News & Analysis

Dolby Laboratories logo
$55.88 +0.62 (+1.13%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$55.50 -0.38 (-0.68%)
As of 05/29/2026 07:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Dolby Laboratories Stock (NYSE:DLB)

Advanced

Key Stats

Today's Range
$55.33
$56.22
50-Day Range
$53.32
$64.95
52-Week Range
$52.45
$77.00
Volume
1.02 million shs
Average Volume
930,116 shs
Market Capitalization
$5.29 billion
P/E Ratio
22.09
Dividend Yield
2.58%
Price Target
$90.75
Consensus Rating
Moderate Buy

Company Overview

Dolby Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
83rd Percentile Overall Score

DLB MarketRank™: 

Dolby Laboratories scored higher than 83% of companies evaluated by MarketBeat, and ranked 61st out of 276 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Dolby Laboratories has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Dolby Laboratories has a consensus price target of $90.75, representing about 62.4% upside from its current price of $55.88.

  • Amount of Analyst Coverage

    Dolby Laboratories has only been the subject of 2 research reports in the past 90 days.

  • Read more about Dolby Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Dolby Laboratories are expected to grow by 5.30% in the coming year, from $3.21 to $3.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Dolby Laboratories is 22.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.89.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Dolby Laboratories is 22.09, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 21.54.

  • Price to Book Value per Share Ratio

    Dolby Laboratories has a P/B Ratio of 2.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Dolby Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    7.82% of the float of Dolby Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Dolby Laboratories has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Dolby Laboratories has recently increased by 7.72%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Dolby Laboratories pays a meaningful dividend of 2.61%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Dolby Laboratories has been increasing its dividend for 10 years.

  • Dividend Coverage

    The dividend payout ratio of Dolby Laboratories is 56.92%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 42.60% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.

  • Read more about Dolby Laboratories' dividend.
  • News Sentiment

    Dolby Laboratories has a news sentiment score of 0.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Discretionary companies.
  • News Coverage This Week

    MarketBeat has tracked 19 news articles for Dolby Laboratories this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for DLB on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Dolby Laboratories to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Dolby Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,805,270.00 in company stock.

  • Percentage Held by Insiders

    37.93% of the stock of Dolby Laboratories is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    58.56% of the stock of Dolby Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Dolby Laboratories' insider trading history.
Receive DLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dolby Laboratories and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

DLB Stock News Headlines

Her 0DTE system hits 87% of the time
A Wall Street insider's 0DTE options system claims an 87 percent hit rate by tracking where institutional money flows in the final hour of trading - before the big moves happen. Users of the system report gains like $5,000 in minutes and accounts growing from $100K to $700K in months. The methodology is documented and available to review.tc pixel
See More Headlines

DLB Stock Analysis - Frequently Asked Questions

Dolby Laboratories' stock was trading at $64.22 at the start of the year. Since then, DLB stock has decreased by 13.0% and is now trading at $55.8820.

Dolby Laboratories (NYSE:DLB) posted its earnings results on Thursday, April, 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping analysts' consensus estimates of $1.31 by $0.06. The company's revenue was up 7.0% on a year-over-year basis.
Read the conference call transcript
.

Dolby Laboratories' Board of Directors approved a share repurchase plan on Wednesday, August 7th 2024, which authorizes the company to repurchase $350,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 5% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's management believes its shares are undervalued.

Dolby Laboratories subsidiaries include Voxeet, Doremi Labs, Step Labs, Coding Technologies, Dolby International AB, and Dolby Laboratories Licensing Corporation.

Top institutional investors of Dolby Laboratories include Bank of New York Mellon Corp (4.71%), First Trust Advisors LP (2.38%), Dimensional Fund Advisors LP (1.38%) and Boston Trust Walden Corp (0.47%). Insiders that own company stock include John D Couling, Kevin J Yeaman, Robert J Park, Shriram Revankar, Mark Andrew Sherman, Todd Pendleton and Ryan Nicholson.
View institutional ownership trends
.

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dolby Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
4/30/2026
Record date for 5/20 Dividend
5/12/2026
Ex-Dividend for 5/20 Dividend
5/12/2026
Dividend Payable
5/20/2026
Today
5/30/2026
46th Annual William Blair Growth Stock Conference
6/03/2026
2026 Baird Global Consumer, Technology & Services Conference
6/04/2026
Next Earnings (Estimated)
7/30/2026
Fiscal Year End
9/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
AUDIO/VIDEO PRD
Sub-Industry
Electronic Components
Current Symbol
NYSE:DLB
CIK
1308547
Employees
2,051
Year Founded
1965

Price Target and Rating

High Price Target
$114.00
Low Price Target
$74.00
Potential Upside/Downside
+62.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.53
Trailing P/E Ratio
22.09
Forward P/E Ratio
17.41
P/E Growth
N/A
Net Income
$255.02 million
Net Margins
17.85%
Pretax Margin
21.14%
Return on Equity
11.47%
Return on Assets
9.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.98
Quick Ratio
2.91

Sales & Book Value

Annual Sales
$1.35 billion
Price / Sales
3.92
Cash Flow
$4.32 per share
Price / Cash Flow
12.94
Book Value
$27.77 per share
Price / Book
2.01

Miscellaneous

Outstanding Shares
94,600,000
Free Float
58,717,000
Market Cap
$5.29 billion
Optionable
Optionable
Beta
0.86

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:DLB) was last updated on 5/30/2026 by MarketBeat.com Staff.
From Our Partners